Cardiology
TIMI risk score changes are more common in multiple risk-factor patients including diabetes
Published in Obesity and Diabetes Week, May 15th, 2006
"Among 4,333 patients who were triaged in the emergency department (ED) over a 1-year period in 2003 because of acute chest pain, 1,747 (40%) were stratified as 'low risk' on the basis of a Thrombolysis In Myocardial Infarction (TIMI) risk score of 0 to 2," researchers in Italy report.
F. Pelliccia and colleagues working with the San Filippo Neri Hospital discovered "during ED stay, TIMI risk score increased to {{>=}}3 in 63% of patients and that such patients were more likely to be diabetic, hypertensive,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Genetics & Genomics
Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity - Obesity & Cardiology
High leptin levels in obese may be beneficial to coronary endothelium - Obesity & Cardiology
PPAR-agonist improves left ventricular function in obese dyslipidemic mice - Obesity & Metabolic Syndrome
Obesity and leukocyte count link was dependent on the presence of metabolic syndrome - Obesity Pathogenesis
ENPP1, an insulin receptor inhibitor, is a genetic link between obesity and diabetes - Angiology
Endothelial cell progenitors display differential healing activities - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
